![Dmitri Bobilev](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dmitri Bobilev
Technik-/Wissenschafts-/F&E-Leiter bei
FUSN PHAR
Profil
Dmitri Bobilev is currently the Chief Medical Officer at Fusion Pharmaceuticals, Inc. Prior to his current position, he worked as the Head of Clinical Development and Vice President at Vedanta Biosciences, Inc. from 2018 to 2020.
He also held the position of Vice President and Head of Clinical Development at Checkmate Pharmaceuticals, Inc. Dr. Bobilev earned a doctorate degree from Omsk State Medical Academy.
Aktive Positionen von Dmitri Bobilev
| Unternehmen | Position | Beginn |
|---|---|---|
| FUSN PHAR | Technik-/Wissenschafts-/F&E-Leiter | 07.11.2022 |
Ehemalige bekannte Positionen von Dmitri Bobilev
| Unternehmen | Position | Ende |
|---|---|---|
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Corporate Officer/Principal | 01.08.2020 |
| CHECKMATE PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Dmitri Bobilev
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
Omsk State Medical Academy
 Omsk State Medical Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
